当前位置：首页 > 文献互助 > 互助详情

Kinase inhibition for nononcologic diseases复制

用户jriCSL6xNpu8 1小时前 19 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-09-25 13:59:08 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接: https://www.sciencedirect.com/science/chapter/edited-volume/abs/pii/B9780443439742000094复制

其他信息:

Z Xie, X Hu, C Liao
Kinase Targets and Drug Discovery, 2026
Elsevier
… Cocrystal structures of abrocitinib bound to JAK1 and JAK2 … In 2021 and 2022, abrocitinib
was approved by the European … assess the efficacy of abrocitinib in alleviating severe fatigue …

上一篇：Synthesis of monophosphines directly from white phosphorus

下一篇：The Substitute Groups in FDA-Approved Small Molecule Drugs in 2020 – 2024

互助时间线

2026-09-18 14:45:10 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2026-09-18 13:59:08 [上传文件]

jodie0105上传了文件(pdf 2.03 MB), 求助状态变成 待确认

2026-09-18 13:44:06 [发起求助]

最新发布的求助

Constructing S-scheme PDPB/Ag–TiO2 heterojunctions with a powerful internal electric field for facilitating photocatalytic hydrogen evolution 9分钟前
The first one-pot synthesis of 1,3-dicarbonyl adamantanes from 1-bromoadamantanes 25分钟前
Inhaled heparin: Past, present, and future 29分钟前
Synthesis of Functional Derivatives of Tricyclic Hydrocarbons 35分钟前
Refractory Normocomplementemic Urticarial Vasculitis With Sustained Remission on Upadacitinib 38分钟前
儿童青少年骨龄发育提前现状及其与体重指数及骨密度关系 1小时前
Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial 1小时前
The Substitute Groups in FDA-Approved Small Molecule Drugs in 2020 – 2024 1小时前
Kinase inhibition for nononcologic diseases 1小时前
Synthesis of monophosphines directly from white phosphorus 5小时前
Google-Search Data for Psychological Scientists: A Tutorial and Best Practices 5小时前
Myeloid-derived suppressor cells in the tumor microenvironment: cellular crosstalk, immunosuppressive effects, and therapeutic targets. 5小时前

wispass工作室 Copyright © 蜀ICP备20005939号-4 www.wispass.com